You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 18, October 8, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Osteoporosis
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS & OPINIONS
High-Sensitivity C-Reactive Protein and Prediction of Nontraumatic Fractures—Reply

Georg Schett, MD; Stefan Kiechl, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

The primary aim of our study was to test whether low-grade systemic inflammation as estimated by hs-CRP level is linked to the risk of nontraumatic fractures.1 The hypothesis that inflammation interferes with bone metabolism and affects fracture risk is intriguing from a pathophysiologic and therapeutic viewpoint. Our and other recent epidemiological data1-2 support this view and intend to stimulate further research efforts in the field.

We, however, fully agree with Cheng that development and validation of a risk score considering well-established predictors of nontraumatic fractures and novel laboratory markers such as soluble receptor activator of nuclear factor {kappa}B ligand (RANKL)3 and CRP level1 is the next logical step. This work is currently in progress, and preliminary data indicate that addition of RANKL and CRP level to a base model including age, sex, and menopausal status results in a significant gain in area . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

High-Sensitivity C-Reactive Protein and Prediction of Nontraumatic Fractures
Huai yong Cheng
Arch Intern Med. 2007;167(18):2007.
EXTRACT | FULL TEXT  

RELATED ARTICLES

High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
Georg Schett, Stefan Kiechl, Siegfried Weger, Angelo Pederiva, Agnes Mayr, Manuele Petrangeli, Friedrich Oberhollenzer, Rolando Lorenzini, Kurt Redlich, Roland Axmann, Jochen Zwerina, and Johann Willeit
Arch Intern Med. 2006;166(22):2495-2501.
ABSTRACT | FULL TEXT  

High-Sensitivity C-Reactive Protein and Fracture Risk in Elderly Women
Julie A. Pasco, Mark A. Kotowicz, Margaret J. Henry, Geoffrey C. Nicholson, Heather J. Spilsbury, Jeffrey D. Box, and Hans G. Schneider
JAMA. 2006;296(11):1353-1355.
EXTRACT | FULL TEXT  

Soluble RANKL and Risk of Nontraumatic Fracture
Georg Schett, Stefan Kiechl, Kurt Redlich, Friedrich Oberhollenzer, Siegfried Weger, Georg Egger, Agnes Mayr, Josef Jocher, Qingbo Xu, Peter Pietschmann, Steven Teitelbaum, Josef Smolen, and Johann Willeit
JAMA. 2004;291(9):1108-1113.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.